Haystack Oncology – Better decisions with better MRD testing
MRD testing demands the most sensitive ctDNA detection. The Haystack MRD test is a tumor-informed ctDNA test that is specifically designed for post-surgical MRD applications.
Go beyond standard risk assessment for adjuvant chemotherapy guidance to ensure the right treatment for the right person at the right time.
Haystack Oncology was founded to dramatically improve patient outcomes by helping doctors optimize treatment strategies using transformative precision oncology. Learn how we support clinicians and biopharma in our mission by providing better MRD testing for better clinical management and therapeutic development.
Haystack Oncology – Better decisions with better MRD testing